Clinical Trials in Deer River, United States
Locations / Deer River, United States
Delta Trials records 176 clinical trials conducted in Deer River, United States, making it a notable site of clinical research activity. These trials across 835 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 7 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Deer River has changed over time.
176
Total Trials
835
Conditions
7
Terminated since 2020
Browse by condition (835 total)
- Stage iv lung cancer ajcc v8 14 trialsAll Stage iv lung cancer ajcc v8 trials
- Stage iiib lung cancer ajcc v8 9 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Recurrent lung non-small cell carcinoma trials
- Stage iva lung cancer ajcc v8 8 trialsAll Stage iva lung cancer ajcc v8 trials
- Stage ivb lung cancer ajcc v8 8 trialsAll Stage ivb lung cancer ajcc v8 trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- Stage iiia lung cancer ajcc v8 7 trialsAll Stage iiia lung cancer ajcc v8 trials
- Acute myeloid leukemia 7 trialsAll Acute myeloid leukemia trials
- Lung non-small cell carcinoma 7 trialsAll Lung non-small cell carcinoma trials
- Invasive breast carcinoma 6 trialsAll Invasive breast carcinoma trials
- Malignant solid neoplasm 6 trialsAll Malignant solid neoplasm trials
- Breast carcinoma 6 trialsAll Breast carcinoma trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Stage iiic lung cancer ajcc v8 5 trialsAll Stage iiic lung cancer ajcc v8 trials
- All Clinical stage iv cutaneous melanoma ajcc v8 trials
- All Anatomic stage i breast cancer ajcc v8 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- All Anatomic stage iia breast cancer ajcc v8 trials
- All Anatomic stage iiia breast cancer ajcc v8 trials
- Chronic lymphocytic leukemia 4 trialsAll Chronic lymphocytic leukemia trials